MPE Mrv0541 02231216572D 19 20 0 0 0 0 999 V2000 -0.6787 1.3117 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0358 0.8992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7503 1.3117 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0358 0.0742 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 0.7503 -0.3383 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4647 0.0742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.1792 -0.3383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8937 0.0742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.6081 -0.3383 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0 -0.6787 -0.3383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7649 -1.1588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.5719 -1.3303 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -1.9844 -0.6159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.7914 -0.4443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4324 -0.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.6873 0.7818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.4943 0.9534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.0463 0.3403 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.5415 0.3661 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 1 2 2 0 0 0 0 2 3 1 0 0 0 0 2 4 1 0 0 0 0 4 5 1 6 0 0 0 4 10 1 0 0 0 0 4 19 1 1 0 0 0 5 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 8 9 1 0 0 0 0 10 11 2 0 0 0 0 10 15 1 0 0 0 0 11 12 1 0 0 0 0 12 13 1 0 0 0 0 13 14 1 0 0 0 0 13 15 2 0 0 0 0 14 18 2 0 0 0 0 15 16 1 0 0 0 0 16 17 2 0 0 0 0 17 18 1 0 0 0 0 M END > DB03455 > drugbank > [H][C@](NOCCS)(C(O)=O)C1=CNC2=C1C=CC=C2 > InChI=1S/C12H14N2O3S/c15-12(16)11(14-17-5-6-18)9-7-13-10-4-2-1-3-8(9)10/h1-4,7,11,13-14,18H,5-6H2,(H,15,16)/t11-/m1/s1 > FJAWIBGKKKXXAL-LLVKDONJSA-N > C12H14N2O3S > 266.316 > 266.072513014 > 4 > 32 > -0.9995740173627087 > 27.265877072254604 > 1 > 4 > 0 > 1 > (2R)-2-(1H-indol-3-yl)-2-[(2-sulfanylethoxy)amino]acetic acid > 1.27 > 1.5469856223520784 > -3.40 > 0 > -1 > 2 > -1 > 9.948529496742305 > 4.293250257918147 > 2.443525831071116 > 74.35 > 80.6624 > 6 > 1 > 1.06e-01 g/l > tetrahydrofolic acid > 0 > DB03455 > EXPT02219 > experimental > (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid $$$$